Actively Recruiting
Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Led by The Cleveland Clinic · Updated on 2025-12-16
400
Participants Needed
1
Research Sites
582 weeks
Total Duration
On this page
Sponsors
T
The Cleveland Clinic
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.
CONDITIONS
Official Title
Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years old
- Healthy Male & Female voluntary participants
You will not qualify if you...
- Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
- Individuals with hematopoetic diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Actively Recruiting
Research Team
S
Scott Cameron, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here